miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1

Rassenti, 2004, ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia., N Engl J Med, 351, 893, 10.1056/NEJMoa040857

Döhner, 2000, Genomic aberrations and survival in chronic lymphocytic leukemia., N Engl J Med, 343, 1910, 10.1056/NEJM200012283432602

Damle, 1999, Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia., Blood, 94, 1840, 10.1182/blood.V94.6.1840

Chen, 2005, ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia., Blood, 105, 2036, 10.1182/blood-2004-05-1715

Chen, 2002, Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia., Blood, 100, 4609, 10.1182/blood-2002-06-1683

Zupo, 1996, CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis., Blood, 88, 1365, 10.1182/blood.V88.4.1365.bloodjournal8841365

Kipps, 2007, The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia., Best Pract Res Clin Haematol, 20, 415, 10.1016/j.beha.2007.04.001

Stevenson, 2011, B-cell receptor signaling in chronic lymphocytic leukemia., Blood, 118, 4313, 10.1182/blood-2011-06-338855

Wiestner, 2012, Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia., Blood, 120, 4684, 10.1182/blood-2012-05-423194

Mraz, 2013, MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia., Leuk Lymphoma, 54, 1836, 10.3109/10428194.2013.796055

Dorsett, 2008, MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation., Immunity, 28, 630, 10.1016/j.immuni.2008.04.002

O’Connell, 2012, MicroRNAs and hematopoietic cell development., Curr Top Dev Biol, 99, 145, 10.1016/B978-0-12-387038-4.00006-9

Henao-Mejia, 2013, The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis., Immunity, 38, 984, 10.1016/j.immuni.2013.02.021

Guo, 2010, Mammalian microRNAs predominantly act to decrease target mRNA levels., Nature, 466, 835, 10.1038/nature09267

Vigorito, 2007, microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells., Immunity, 27, 847, 10.1016/j.immuni.2007.10.009

Koralov, 2008, Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage., Cell, 132, 860, 10.1016/j.cell.2008.02.020

Mraz, 2012, MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia., Blood, 119, 2110, 10.1182/blood-2011-11-394874

Ebert, 2009, An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a., Nat Immunol, 10, 1162, 10.1038/ni.1797

Li, 2012, Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity., Nat Med, 18, 1518, 10.1038/nm.2963

Klein, 2010, The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia., Cancer Cell, 17, 28, 10.1016/j.ccr.2009.11.019

Lu, 2010, Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses., Cell, 142, 914, 10.1016/j.cell.2010.08.012

Ventura, 2008, Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters., Cell, 132, 875, 10.1016/j.cell.2008.02.019

Rodriguez, 2007, Requirement of bic/microRNA-155 for normal immune function., Science, 316, 608, 10.1126/science.1139253

Calin, 2002, Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia., Proc Natl Acad Sci USA, 99, 15524, 10.1073/pnas.242606799

Lawrie, 2013, MicroRNAs and lymphomagenesis: a functional review., Br J Haematol, 160, 571, 10.1111/bjh.12157

Mraz, 2009, MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes., Leuk Lymphoma, 50, 506, 10.1080/10428190902763517

Mraz, 2012, MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back., Expert Rev Hematol, 5, 579, 10.1586/ehm.12.54

Calin, 2005, A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia., N Engl J Med, 353, 1793, 10.1056/NEJMoa050995

Stamatopoulos, 2009, microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification., Blood, 113, 5237, 10.1182/blood-2008-11-189407

Rossi, 2010, microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival., Blood, 116, 945, 10.1182/blood-2010-01-263889

Fulci, 2007, Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia., Blood, 109, 4944, 10.1182/blood-2006-12-062398

Mraz, 2009, miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities., Leukemia, 23, 1159, 10.1038/leu.2008.377

Visone, 2011, miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia., Blood, 118, 3072, 10.1182/blood-2011-01-333484

Cimmino, 2005, miR-15 and miR-16 induce apoptosis by targeting BCL2., Proc Natl Acad Sci USA, 102, 13944, 10.1073/pnas.0506654102

Mott, 2007, mir-29 regulates Mcl-1 protein expression and apoptosis., Oncogene, 26, 6133, 10.1038/sj.onc.1210436

Pekarsky, 2006, Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181., Cancer Res, 66, 11590, 10.1158/0008-5472.CAN-06-3613

Tili, 2012, The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state., Blood, 120, 2631, 10.1182/blood-2012-03-415737

Chuang, 2012, Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression., Blood, 120, 2639, 10.1182/blood-2012-03-416461

Mraz, 2009, MicroRNA isolation and stability in stored RNA samples., Biochem Biophys Res Commun, 390, 1, 10.1016/j.bbrc.2009.09.061

Dolezalova, 2012, MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells., Stem Cells, 30, 1362, 10.1002/stem.1108

Chen, 2008, ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia., Blood, 111, 2685, 10.1182/blood-2006-12-062265

Friedman, 2009, Most mammalian mRNAs are conserved targets of microRNAs., Genome Res, 19, 92, 10.1101/gr.082701.108

Luo, 2013, MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1., Stem Cells, 31, 1749, 10.1002/stem.1448

Wu, 2010, MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2., Biochem Biophys Res Commun, 392, 340, 10.1016/j.bbrc.2009.12.182

Yu, 2013, Expression of microRNA-150 targeting vascular endothelial growth factor-A is downregulated under hypoxia during liver regeneration., Mol Med Rep, 8, 287, 10.3892/mmr.2013.1493

Zhou, 2013, miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1., J Am Soc Nephrol, 24, 1073, 10.1681/ASN.2012080849

Xiao, 2007, MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb., Cell, 131, 146, 10.1016/j.cell.2007.07.021

Xiao, 2009, MicroRNA control in the immune system: basic principles., Cell, 136, 26, 10.1016/j.cell.2008.12.027

Bartel, 2009, MicroRNAs: target recognition and regulatory functions., Cell, 136, 215, 10.1016/j.cell.2009.01.002

Akbari Moqadam, 2013, The hunting of targets: challenge in miRNA research., Leukemia, 27, 16, 10.1038/leu.2012.179

Ingham, 2001, The Gab1 docking protein links the b cell antigen receptor to the phosphatidylinositol 3-kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase., J Biol Chem, 276, 12257, 10.1074/jbc.M010590200

Hu, 2006, Foxp1 is an essential transcriptional regulator of B cell development., Nat Immunol, 7, 819, 10.1038/ni1358

Brown, 2008, Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL., Blood, 111, 2816, 10.1182/blood-2007-09-115113

Bracken, 2008, A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition., Cancer Res, 68, 7846, 10.1158/0008-5472.CAN-08-1942

Arvey, 2010, Target mRNA abundance dilutes microRNA and siRNA activity., Mol Syst Biol, 6, 363, 10.1038/msb.2010.24

Thomas, 2005, c-Myb is critical for B cell development and maintenance of follicular B cells., Immunity, 23, 275, 10.1016/j.immuni.2005.08.005

Golay, 1992, Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes., J Immunol, 149, 300, 10.4049/jimmunol.149.1.300

Zhou, 2007, miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely., Proc Natl Acad Sci USA, 104, 7080, 10.1073/pnas.0702409104

Green, 2009, Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFkappaB activity in Follicular Lymphoma., Leuk Res, 33, 1699, 10.1016/j.leukres.2009.05.004

Sagaert, 2006, Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma., J Clin Oncol, 24, 2490, 10.1200/JCO.2006.05.6150

Barrans, 2004, Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome., Blood, 104, 2933, 10.1182/blood-2004-03-1209

Choi, 2009, A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy., Clin Cancer Res, 15, 5494, 10.1158/1078-0432.CCR-09-0113

Sagardoy, 2013, Downregulation of FOXP1 is required during germinal center B-cell function., Blood, 121, 4311, 10.1182/blood-2012-10-462846

Lin, 2014, FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacological inhibition of the PI3K-AKT pathway., Cancer Res, 74, 1682, 10.1158/0008-5472.CAN-13-1729

Sármay, 2006, The multiple function of Grb2 associated binder (Gab) adaptor/scaffolding protein in immune cell signaling., Immunol Lett, 104, 76, 10.1016/j.imlet.2005.11.017